Dilaterol vet.

1 x 355 ml

Sirup / Saft

Active substance

Clenbuterol (Clenbuterol hydrochloride) : 25 mikg/ml

ATC code

QR03CC13 Clenbuterol

QR03CC Selective beta-2-adrenoreceptor agonists

QR03C Adrenergics for systemic use

QR03 Drugs for obstructive airway diseases

QR Respiratory system

Species

Horses.

Indications

Treatment of respiratory disease in horses where it is considered that airway obstruction due to bronchospasm and/or accumulation of mucus is a contributing factor, and improved mucociliary clearance is desirable. To be used alone or as adjuvant therapy.

Dose to be administered and administration route

For oral use.

Each depression of the pump delivers 4 ml of product (0.100 mg of clenbuterol hydrochloride, equivalent to 0.088 mg clenbuterol).

The pump needs to be primed before the first use only. Prime the pump by pressing twice and discard the retrieved syrup.

It is not possible to extract all the contents using the pump provided.

Administer 4 ml of the product per 125 kg bodyweight twice daily.

This is equivalent to twice daily administration of 0.8 micrograms clenbuterol hydrochloride per kg bodyweight.

The syrup should be added to the feed.

Treatment should continue for as long as necessary.

Adverse reactions

Rare

(1 to 10 animals / 10,000 animals treated):

Restlessness;

Tachycardia, Hypotension^a;

Muscle tremor;

Hyperhidrosis^b

^a slight

^b mainly neck region

These adverse events are typical for β-agonists.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.